期刊文献+

唾液腺腺样囊性癌组织中ERK蛋白的表达及其临床意义 被引量:1

Expression of ERK in salivary adenoid cystic carcinoma and its clinical significance
下载PDF
导出
摘要 目的探讨唾液腺腺样囊性癌(SACC)组织中有丝分裂活化蛋白激酶(ERK)的表达及临床意义。方法采用免疫组化法(SP法)检测63例SACC组织中ERK的表达,数据采用χ2和t检验进行显著性比较。结果在带有癌旁非癌组织的38个病例中,所有唾液腺腺样囊性癌组织中均有ERK蛋白表达,在癌旁非癌组织中ERK表达阳性31例(52.63%),两者的差异有显著性(P<0.01);在25例有转移病例中ERK表达阳性24例(96%),在38例无转移病例中ERK表达阳性27例(71.05%),两者的差异有显著性(P<0.05);而ERK的表达在年龄、性别和病理分型上均无显著性差异(P>0.05)。结论ERK的高表达可能与唾液腺腺样囊性癌的发生发展密切相关,是患者预后的重要指标之一。 Objective To investigate the expression of extracellular signal-regulated kinase(ERK) in salivary adenoid cystic carcinoma and its clinical significance. Methods The expression of ERK in salivary adenoid cystic carcinoma was evaluated by SP immunohistochemistry. Results In 38 cases of non-cancer tissue nearby cancer, 31(81.58% ) cancer tissue ERK expressions were found positive. 20(52.63 % ) non-cancer tissue nearby cancer ERK expressions were found positive. There was significant difference in cancer tissue and non-cancer tissue nearby cancer( P 〈 0,01 ). In 25 cases with metastasis, in 24(96% ) cases ERK expressions were found positive. In 38 cases with non-metastasis, in 27(71.05%) cases ERK expressions were found positive. There was significant difference in cases of metastasis and non-metastasis ( P 〈 0.05). There was no significant difference between the different sek, age and sorts of pathology( P 〉 0.05). Conclusions The expressions of ERK may be related to occurrence and progress of salivary adenoid cystic carcinoma, and it may reflect the metastasis.
出处 《口腔医学》 CAS 2007年第8期421-423,共3页 Stomatology
关键词 唾液腺腺样囊性癌 有丝分裂活化蛋白激酶 salivary adenoid cystic carcinoma(SACC) extracellular signal-regulated kinase(ERK)
  • 相关文献

参考文献6

  • 1Johnson GL,Lapadat R.Mitogen-activated protein kinase pathways mediated by ERK,JNK,and p38 protein kinases[J].Science,2002,298(5600):1911-1912.
  • 2Bresalier RS,Ho SB,Schoeppner HL,et al.Enhanced sialylation of mucin-assocciated carbohydrate structures in human colon cancer metastasis[J].Gastroenterology,1996,110(5):1354-1367.
  • 3Whitmarsh AJ,Davis RJ.Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways[J].J Mol Med,1996,74(10):589-607.
  • 4叶定伟,李慧,Priscilla Chauvin,孙颖浩,钱松溪,郑家富,马永江.有丝分裂激活蛋白激酶激活与前列腺癌的恶化进展[J].肿瘤防治杂志,2002,9(2):157-158. 被引量:14
  • 5Tsang KJ,Crowe DL.Retinoic acid and extracellular matrix inhibition of matrix metalloproteinase 9 expression is mediated by the mitogen activated protein kinase pathway[J].Int J Oncol,2001,18(2):369-374.
  • 6王秋旭,沈磊,孙长伏.口腔鳞状细胞癌ERK蛋白表达与临床分期、淋巴结转移的关系[J].上海口腔医学,2005,14(1):18-20. 被引量:3

二级参考文献7

  • 1叶定伟 李慧 等.人前列腺癌组织中MAPK的激活[J].临床泌尿外科杂志,2001,15:66-67.
  • 2Bresalier RS, Ho SB, Schoeppner HL, et al. Enhanced sialylation of mucin-associated carbohydrate structures in human colon cancer metastasis[J]. Gastroenterology, 1996, 110(5):1354-1367.
  • 3Patton SE, Martin ML, Nelsen LL, et al. Activation of the rasmitogen-activated protein kinase pathway and phosphorylation of ets-2 at position threonine 72 in human ovarian cancer cell lines [J]. Cancer Res, 1998, 58(10):2253-2259.
  • 4Simon C, Hicks MJ, Nemechek AJ, et al. PD098059, an inhibitor of ERK1 activation, attenuates the in vivo invasiveness of head and neck squamous cell carcinoma[J]. Br J Cancer, 1999, 80(9):1412-1419.
  • 5Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases[J]. Science,2002,298(5600):1911-1912.
  • 6叶定伟,李慧,Jane Tseng,Priscilla Chauvin,钱松溪,孙颖浩,郑家富,马永江.有丝分裂激活蛋白激酶在人前列腺癌细胞中的激活[J].中华泌尿外科杂志,2001,22(5):290-292. 被引量:4
  • 7叶定伟,李慧,Priscilla Chauvin,孙颖浩,钱松溪,郑家富,马永江.有丝分裂激活蛋白激酶激活与前列腺癌的恶化进展[J].肿瘤防治杂志,2002,9(2):157-158. 被引量:14

共引文献14

同被引文献21

  • 1卿菁,张诠,魏茂文,郭朱明.64例大涎腺腺样囊性癌的预后因素分析[J].癌症,2006,25(9):1138-1143. 被引量:15
  • 2卢友光,周鸿鹰,丁林灿,梅妍,熊若虹,邓世山,羊惠君.涎腺腺样囊性癌高、低转移细胞系基因表达谱及基质金属蛋白酶表达差异[J].中华医学遗传学杂志,2006,23(5):505-510. 被引量:18
  • 3卢友光,丁林灿,周鸿鹰,邓世山,王启明,熊若虹,羊惠君.MMPs及TIMPs在ACC-M、ACC-2裸鼠移植瘤中的表达[J].上海口腔医学,2006,15(5):526-530. 被引量:6
  • 4Barnes L,Eveson J W,Reichart P,et al.头颈部肿瘤病理学和遗传学[M] //刘红刚,高岩,主译.北京:人民卫生出版社,2006:245-328.
  • 5Roberts PJ, Der CJ. Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer[J]. Oncogene, 2007, 26(22):3291-3310.
  • 6Munshi HG, WU YI, Mukhopadhvav S, et al. Differential regulation of membrane type 1-matrix metalloproteinase activity by ERK 1/2- and p38 MAPK-modulated tissue inhibitor of metalloproteinases 2 expression controls transforming growth factor betal-induced pericellular collagenolysis[J]. Biol Chem, 2004. 279(37):39042-39050.
  • 7Handra-Luca A, Mauguen A, Menard P, et al.Coordinated expression of activated mitogen-activated protein kinases in salivary gland adenoid cystic carcinoma[J]. Hum Pathol, 2008, 39(11):1590-1596.
  • 8Nagel H, Laskawi R, Wahlers A, et al. Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, -2,and-3 in benign and malignant tumours of the salivary gland[J]. Histopathology, 2004, 44(3): 222-231.
  • 9Kim ES, Kim MS, Moon A. Transforming growth factor (TGF)- beta in conjunction with H-ras activation promotes malignant progression of MCF10A breast epithelial cells[J]. Cytokine, 2005, 29(2): 84-91.
  • 10Luukkaa H, Klemi P, Hirsimaki P, et al. Matrix metalloproteinase (MMP)-1,-9and -13 as prognostic factors in salivary gland cancer[J]. Axta Otolaryngol, 2008, 128(4): 482-490.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部